FDA Category 2 status AOD-9604 was previously nominated for inclusion under FDA's Category 2 list (substances proposed for compounding under research/evaluation)
The work below comes from preclinical studies, not from proven effects in people
However, it is also possible that the effects of these drugs on the brain could be positive, particularly in older adults with pre-diabetes or diabetes, where controlling insulin dynamics might be beneficial for preventing Alzheimer's disease 6m20s
Boosts energy and improved my mood
BPC-157 does not directly improve sleep through hormonal mechanisms, though reducing chronic pain or inflammation may indirectly improve sleep quality in patients whose sleep is disrupted by physical discomfort
This article does not diagnose, treat, or prescribe